Dermatology Times Staff

Ixekizumab demonstrated long-term efficacy in treating psoriasis and psoriatic arthritis across five years, according to data presented by Eli Lilly at the 29th annual European Academy of Dermatology and Venereology (EADV) Congress.

Click to answer our weekly poll.

A glimpse at what to expect from Dermatology Times this week.

What’s more frightful than Halloween? What the makeup and costumes can do to children’s and adult’s skin. Dermatologists weigh in with their top tips to help patients avoid post-Halloween skin horrors.

A glimpse at what to expect from Dermatology Times this week.

A glimpse at what to expect from Dermatology Times this week.

A glimpse at what to expect from Dermatology Times this week.

Top educators in dermatology will come together to deliver CME lectures and engaging panel discussions via a premiere virtual platform. Learn more about MauiDerm Connect coming September 23-27.

In this webinar, moderated by Daniel Siegel, M.D., M.A., FAAD, FACMS, experts discuss guidance on the use of teledermatology and ways to successfully implement new models of care during the COVID-19 pandemic.

A middle-aged male patient with a superficial lesion on right upper back.

Read the highlights from our February 2020 issue in the slideshow below.

View the highlights from our January 2020 issue in this slideshow.

In this slideshow, review the advancements, changes and trends that shaped dermatology in 2019.

From plasma energy to CBD in skincare, these are a few of the hot topics the Dermatology Times team covered in 2019 that are worthy of keeping an eye on in 2020.

To recognize Antibiotic Awareness Week, we’ve gathered articles on antibiotic use in acne, alternative therapies and treatment trends in the specialty. View the highlights in this slideshow.

In this interview, Dr. Anna De Benedetto discusses what initially drew her to dermatology and what inspired her to study atopic dermatitis in the elderly.

To recognize the one year anniversary of our Innovation column, the Dermatology Times Staff has compiled key takeaways from topics covered throughout the year. View them in this slideshow.

Refresh your memory on treatment guidelines for mild, moderate and severe acne in this easy-to-view slideshow.

LEO Pharma has submitted an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for the study of an oral atopic dermatitis treatment, JW1601/LP0190, according to a company announcement. 

Cassiopea SpA submitted a New Drug Application (NDA) to the U.S. Federal Drug Administration (FDA) for its novel acne treatment, clascoterone cream 1%, according to a company announcement released today.

The U.S. Food and Drug Administration (FDA) accepted a new drug application (NDA) for Ortho Dermatologics’ novel tazarotene O.045% lotion (IDP-123) with a PDUFA action date of Dec. 22, 2019, according a recent announcement from the company.

In this on-going article, we plan to highlight new skincare products as they are released. Bookmark this page to stay up-to-date as we will update it every month.

In this table, we highlight how psoriasis treatments have evolved over the past four decades. 

Some chemicals in over-the-counter sunscreens may impair marine life, says the National Ocean Service. As a result, they are recommending people choose sunscreens without these chemicals ingredients.